Expert panel will explore research quality and solutions for what CAN be fixed; New Reproducibility2020 initiative will provide framework for action
On Tuesday, February 9, at 12:00 noon EST, Global Biological Standards Institute (GBSI) will host its 2016 BioPolicy Summit at the Newseum in Washington, DC. The 2016 Summit—Research Reproducibility: Innovative Solutions to Drive Quality welcomes premiere life science thought leaders as speakers, panelists and guests who will review the complex causes of irreproducibility and focus on tangible solutions to drive greater research quality and accelerate the discovery of life-saving therapies.
The Summit will also introduce GBSI’s Reproducibility2020, an action plan for the biomedical research community to significantly improve the quality of research by 2020 targeting: 1) improved validation and standardization of biological reagents; 2) better tools and technologies to expand open access for reporting and sharing protocols and data; and 3) increased training that emphasizes rigorous study design and practice.
Panelists will identify calls-to-action for attendees to implement in their own areas of expertise to bring about change in the development of biomedical research standards and best practices. A question and answer session will provide attendees the opportunity to further probe the insights and contributions of presenters and offer their own perspective.
Advances in life science research are based on the quality, reproducibility and translatability of published data and findings. Yet irreproducibility in preclinical research is pervasive and contributes to delays and costs in therapeutic drug development and reduced trust in the biomedical research process. Myriad factors lead to irreproducibility; solutions will result in more cost-effective research and accelerate the discovery of diagnostics and treatments that can save lives.
Media are invited to RSVP to attend the Summit by emailing firstname.lastname@example.org. A live webcast will be available for those who would like to participate remotely.
PROGRAM & DETAILS:
Registration and Lunch Buffet (11:30 p.m.)
Welcome (12:00 noon): Leonard P. Freedman PhD, President, Global Biological Standards Institute
Keynote presenter: Judith Kimble, PhD, Vilas Professor of Biochemistry, Molecular Biology, Medical Genetics and Cell and Regenerative Biology at the University of Wisconsin–Madison; Investigator, Howard Hughes Medical Institute will cover the broader challenges around reproducibility in research.
Panel (12:30 p.m. – 1:30 p.m.)
Moderator: Richard Harris, award-winning journalist and Science Correspondent, National Public Radio. Currently on leave, he is writing a book about rigor and reproducibility in biomedical science, and he’s a visiting scholar at Arizona State University. The panel features:
Simcoe and Freedman can both answer questions about the provocative paper they co-authored and published in PLOS with Iain M. Cockburn PhD last year, The Economics of Reproducibility in Preclinical Research—in terms of what the authors’ intent in quantifying the cost of irreproducibility was, and what they found.
Q&A: (1:30 p.m.)
Closing Remarks (before 2:00 p.m.): Leonard Freedman
Date: Tuesday, February 9, 2016; 12 to 2 p.m. EST (lunch buffet at 11:30 a.m.)
Location: The Newseum, Knight Conference Center; 555 Pennsylvania Avenue NW, Washington, DC 20001
About Global Biological Standards Institute (GBSI)
GBSI, a non-profit organization, is dedicated to enhancing the quality of biomedical research by advocating best practices and standards to accelerate the translation of research breakthroughs into life-saving therapies. For more information, visit GBSI.org; Twitter @GBSIorg.